The HER2 positive
advanced or metastatic gastric cancer (GC) is recommended
with Trastuzumab (Tmab) combined cisplatin (CDDP) and capecitabine (Cap).
Otherwise,
oxaliplatin (L-OHP) has been replaced in place of CDDP for GC. Furthermore, S-1
is a key oral anticancer drug used in the treatment of gastrointestinal cancer
in Asia.
A 59- year-old
man who received Tmab-SOX therapy for solitary synchronous liver metastasis of
GC, because the operated intestinal type GC revealed HER2 score 3+
immunohistochemically.
No comments:
Post a Comment